Source: The Pharma Letter

ASLAN Pharmaceuticals: Aslan files for voluntary liquidation

The show is over for Aslan Pharmaceuticals, the immunology-focused biopharmaceutical company, as its financial troubles have led it to file for voluntary liquidation.

Read full article »
ASLAN Pharmaceuticals's Competitors | ASLAN Pharmaceuticals's News | ASLAN Pharmaceuticals's Financials
Stay up-to-date with the latest news on ASLAN Pharmaceuticals
Annual Revenue
$5.0-25M
Employees
25-100
Carl Firth's photo - Founder & CEO of ASLAN Pharmaceuticals

Founder & CEO

Carl Firth

CEO Approval Rating

89/100

Read more
Stay up-to-date with the latest news on ASLAN Pharmaceuticals